Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/76834
Full metadata record
DC FieldValueLanguage
dc.creatorSusana Pereira
dc.creatorFilipa Fontes
dc.creatorTeresa Sonin
dc.creatorTeresa Dias
dc.creatorMaria Fragoso
dc.creatorJosé Castro Lopes
dc.creatorNuno Lunet
dc.date.accessioned2019-02-03T19:31:48Z-
dc.date.available2019-02-03T19:31:48Z-
dc.date.issued2014
dc.identifier.issn2044-6055
dc.identifier.othersigarra:94175
dc.identifier.urihttps://repositorio-aberto.up.pt/handle/10216/76834-
dc.description.abstractIntroduction: The improvement in breast cancer survival rates, along with the expected overdiagnosis and overtreatment associated with breast cancer screening, requires a comprehensive assessment of its burden. Neurological complications can have a devastating impact on these patients; neuropathic pain and chemotherapy-induced peripheral neuropathy are among the most frequently reported. This project aims to understand the burden of neurological complications of breast cancer treatment in Northern Portugal, and their role as mediator of the impact of the treatment in different dimensions of the patients' quality of life. Methods and analysis: A prospective cohort study was designed to include 500 patients with breast cancer, to be followed for 3 years. The patients were recruited at the Portuguese Oncology Institute of Porto and evaluations were planned at different stages: pretreatment, after surgery, after chemotherapy (whenever applicable) and at 1 and 3 years after enrolment. Patients diagnosed with neuropathic pain or chemotherapy-induced peripheral neuropathy (subcohorts), were also evaluated at the moment of confirmation of clinical diagnosis of the neurological complication and 6 months later. In each of the follow-up periods, a neurological examination has been performed by a neurologist. Data were collected on sociodemographic and clinical characteristics, quality of life, sleep quality, and anxiety and depression. Between January and December 2012, we recruited and conducted the baseline evaluation of 506 participants. The end of the follow-up period is scheduled for December 2015. Ethics and dissemination: The study protocol was approved by the Ethics Committee of the Portuguese Oncology Institute of Porto and all patients provided written informed consent. All study procedures were developed in order to assure data protection and confidentiality. Results from this project will be disseminated in international peer-reviewed journals and presented in relevant conferences.
dc.language.isoeng
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.subjectMedicina, Medicina clínica
dc.subjectMedicine, Clinical medicine
dc.titleNeurological complications of breast cancer: study protocol of a prospective cohort study
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoFaculdade de Medicina
dc.identifier.doi10.1136/bmjopen-2014-006301
dc.identifier.authenticusP-009-YTY
dc.subject.fosCiências médicas e da saúde::Medicina clínica
dc.subject.fosMedical and Health sciences::Clinical medicine
Appears in Collections:FMUP - Artigo em Revista Científica Internacional
ISPUP - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
94175.pdf1.35 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons